OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
Zeng Zhang, Xin Tan, Zengxin Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Zeng Zhang, Xin Tan, Zengxin Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
FSP1 is a predictive biomarker of osteosarcoma cells’ susceptibility to ferroptotic cell death and a potential therapeutic target
Elżbieta Pańczyszyn, Valentina Saverio, Romina Monzani, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Elżbieta Pańczyszyn, Valentina Saverio, Romina Monzani, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Promise and Challenges of T Cell Immunotherapy for Osteosarcoma
Jeong A Park, Nai‐Kong V. Cheung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12520-12520
Open Access | Times Cited: 18
Jeong A Park, Nai‐Kong V. Cheung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12520-12520
Open Access | Times Cited: 18
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment
Cheng Peng, Chaoqun You, Shuang Cao, et al.
Analytical Cellular Pathology (2025) Vol. 2025, Iss. 1
Open Access
Cheng Peng, Chaoqun You, Shuang Cao, et al.
Analytical Cellular Pathology (2025) Vol. 2025, Iss. 1
Open Access
Neutrophil extracellular traps are associated with poor response to neoadjuvant therapy and poor survival in pediatric osteosarcoma
Szilvia Baron, Yoav Binenbaum, Ronny Maman, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Szilvia Baron, Yoav Binenbaum, Ronny Maman, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma
Lidia Tarone, Davide Giacobino, Mariateresa Camerino, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2342-2359
Open Access | Times Cited: 10
Lidia Tarone, Davide Giacobino, Mariateresa Camerino, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2342-2359
Open Access | Times Cited: 10
Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment
Abinaya Shanmugavadivu, Sundaravadhanan Lekhavadhani, P J Miranda, et al.
Biomedical Materials (2024) Vol. 19, Iss. 2, pp. 022003-022003
Closed Access | Times Cited: 3
Abinaya Shanmugavadivu, Sundaravadhanan Lekhavadhani, P J Miranda, et al.
Biomedical Materials (2024) Vol. 19, Iss. 2, pp. 022003-022003
Closed Access | Times Cited: 3
METTL3-mediated m6A modification of circRNF220 modulates miR-330-5p/survivin axis to promote osteosarcoma progression
Feng Liu, Wen Li, Zhihui Jin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17347-17360
Open Access | Times Cited: 7
Feng Liu, Wen Li, Zhihui Jin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17347-17360
Open Access | Times Cited: 7
Tumor-secreted extracellular vesicles counteract therapy response by triggering inflammatory mesenchymal stem cell development
Crescenzo Massaro, Hilal N. Sensoy, Manon Mulders, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4714-4728
Closed Access | Times Cited: 2
Crescenzo Massaro, Hilal N. Sensoy, Manon Mulders, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4714-4728
Closed Access | Times Cited: 2
CHEMOTHERAPY, IMMUNOTHERAPY, AND TARGETED THERAPY FOR OSTEOSARCOMA: RECENT ADVANCEMENTS
Esther Ekpe Adewuyi, Harshal Chorya, Muili Abdulbasit, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104575-104575
Closed Access | Times Cited: 2
Esther Ekpe Adewuyi, Harshal Chorya, Muili Abdulbasit, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104575-104575
Closed Access | Times Cited: 2
Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer
Hanqing Zhao, Ying Huang, Guoshun Tong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16188-16188
Open Access | Times Cited: 6
Hanqing Zhao, Ying Huang, Guoshun Tong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16188-16188
Open Access | Times Cited: 6
Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma
Yulin Hou, Jie Wang, Jianping Wang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Yulin Hou, Jie Wang, Jianping Wang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma
Qinwen Li, Xiaoyan Huang, Youfang Zhao
Cancer Biotherapy and Radiopharmaceuticals (2023)
Closed Access | Times Cited: 4
Qinwen Li, Xiaoyan Huang, Youfang Zhao
Cancer Biotherapy and Radiopharmaceuticals (2023)
Closed Access | Times Cited: 4
Advances in Target Therapy Research in Osteosarcoma
Caterina Chiappetta, Carlo Della Rocca, Claudio Di Cristofano
(2024)
Open Access | Times Cited: 1
Caterina Chiappetta, Carlo Della Rocca, Claudio Di Cristofano
(2024)
Open Access | Times Cited: 1
Oncolytic Viral Therapy in Osteosarcoma
Thomas Karadimas, Thien Huong Huynh, Chloe Chose, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1139-1139
Open Access | Times Cited: 1
Thomas Karadimas, Thien Huong Huynh, Chloe Chose, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1139-1139
Open Access | Times Cited: 1
Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis
Hanxi Xiao, Nan Jiang, Hongbin Zhang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112672-112672
Closed Access | Times Cited: 1
Hanxi Xiao, Nan Jiang, Hongbin Zhang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112672-112672
Closed Access | Times Cited: 1
He Zhang, Yang Bai, Jiatong Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 1
Tumor microenvironment phenotypes and prognostic evaluation tools for osteosarcoma characterized by different prognostic outcomes and immunotherapy responses
Zubo Tu, Wang Li, Zhigang Chen, et al.
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Zubo Tu, Wang Li, Zhigang Chen, et al.
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Large Scale Comparative Deconvolution Analysis of the Canine and Human Osteosarcoma Tumor Microenvironment Uncovers Conserved Clinically Relevant Subtypes
Sushant Patkar, Josh Mannheimer, Stephanie A. Harmon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Sushant Patkar, Josh Mannheimer, Stephanie A. Harmon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
Sachin G Nair, Sonu Benny, W.M. Jose, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 1, pp. 9-24
Closed Access
Sachin G Nair, Sonu Benny, W.M. Jose, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 1, pp. 9-24
Closed Access
Identifying immune‐related prognostic biomarkers in osteosarcoma: Development and validation of the tumor immune microenvironment risk model based on analysis of TCGA
X. Zhang, Yizhe Fan, Zhongyuan Shen, et al.
Environmental Toxicology (2024)
Closed Access
X. Zhang, Yizhe Fan, Zhongyuan Shen, et al.
Environmental Toxicology (2024)
Closed Access
p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death
Koji Demiya, Hiroshi Tazawa, Hiroya Kondo, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200845-200845
Open Access
Koji Demiya, Hiroshi Tazawa, Hiroya Kondo, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200845-200845
Open Access
Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma
Ryan A. Lacinski, Sebastian A. Dziadowicz, Vincent K Melemai, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access
Ryan A. Lacinski, Sebastian A. Dziadowicz, Vincent K Melemai, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access
Tellurium-Doped Bioactive Glass Induces Ferroptosis in Osteosarcoma Cells Regardless of FSP1
Elżbieta Pańczyszyn, Mari Lallukka, Mara Gagliardi, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1327-1327
Open Access
Elżbieta Pańczyszyn, Mari Lallukka, Mara Gagliardi, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1327-1327
Open Access
